Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease. [electronic resource]
- Journal of Crohn's & colitis Apr 2016
- 395-401 p. digital
Publication Type: Journal Article
1876-4479
10.1093/ecco-jcc/jjv227 doi
Adult Aged Aged, 80 and over Antibodies, Monoclonal--adverse effects Antibodies, Monoclonal, Humanized CTLA-4 Antigen--immunology Colectomy Colon--pathology Enterocolitis--chemically induced Female Humans Immunotherapy--adverse effects Inflammatory Bowel Diseases--chemically induced Ipilimumab Male Melanoma--therapy Middle Aged Young Adult